Person entering Gilead building Leading the pack is Gilead Sciences’ HIV medication Biktarvy, which had U.S. sales revenue five times greater than the rest of the world. (Photo: David Paul Morris/Bloomberg)

Americans spent nearly twice as much on the 20 top-selling pharmaceuticals as the rest of the world combined last year, according to an analysis by the interest group Public Citizen.

“Americans spend far too much on prescription drugs,” according to the report. “Earlier studies have identified that the United States spends more per capita for prescription drugs than any other industrialized nation. In this analysis, we attempted to quantify the spending disparity by analyzing the sources of revenue for the 20 top-selling drugs globally in 2020.”

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.